In particular, the almost $170 million commitment to making Long-Acting Reversible Contraceptives (LARCs) such as IUD’s more widely available is a “hugely positive move,” she said.

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...